Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma

Anticancer Research

Volumn 23, Issue 1 B, 2003, Pages 713-717

  Taguchi, Takahide ^a   Ikeda, Yoichi ^a   Mikami, Yasukazu ^a   Kawai, Satoshi ^a   Arai, Yasuhiro ^a   Mochimatsu, Idumi ^a   Tsukuda, Mamoru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Carboplatin; Chemoradiotherapy; Head and neck cancer; Radiotherapy; UFT

Indexed keywords

CARBOPLATIN; FLUOROURACIL; UFT;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY; TEGAFUR; URACIL;

EID: 0037231279     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Douple EB, Richmond RC, O'Hara JA and Coughlin CT: Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 12(Supl A): 111-124, 1985.
2. Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BJ, Wanamaker JR, Eliachar I, Strome M and Van Kirk MA: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19: 567-575, 1997.
3. Calaris G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P and Bertrand P: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91: 2081-2086, 1999.
4. Jeremic B, Shibamoto Y, Stanisavljevis B, Milojevic L, Milicic B and Nikolic N: Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 43: 29-37, 1997.
5. Eisenberger M, Hornedo J, Silva H, Donehower R, Spaulding M and Van Echo D: Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 4: 1505-1509, 1986.
6. de Andres Basauri L, Lopez Pausa A, Alba E and Sampedro F: Carboplatin, an active drug in advanced head and neck cancer. Cancer Treat Rep 70: 1173-1176, 1986.
7. Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH and Harrap KR: Pharmacokinetics of cis-diammine-1, 1-cyclobutane dicarboxylate platinum (II) in patients with normal and impaired renal function. Cancer Res 44: 1693-1697, 1984.
8. Vokes EE and Weichselbaum RR: Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8: 911-934, 1990.
9. Osoba D, Flores AD, Hay JH, Wong F and Maher M: Phase I study of concurrent carboplatin and radiotherapy in previously untreated patients with stage III and IV head and neck cancer. Head Neck 13: 217-223, 1991.
10. Zamboglou N, Achterrath W, Schnabel T, Lenaz I, Kolotas C and Schmitt G: Simultaneous radiotherapy and chemotherapy with carboplatin in inoperable squamous cell carcinoma of the head and neck: a phase II study. Cancer Invest 10: 349-355, 1992.
11. Jacobs MC, Eisenberger M, Oh MC, Sinibaldi V, Gray W, Elias G and Salazar OM: Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: a phase I-II study. Int J Radiot Oncol Biol Phys 17: 361-363, 1989.
12. Jeremic B, Zivic DJ, Djuric LJ and Mijatovic LJ: Carboplatin and radiation therapy for stage IV carcinoma of the head and neck. Preliminary results of a phase II study. J Chemother 4: 180-184, 1992.
13. Minsky BD: UFT plus oral leucovorin calcium (Orzel) and radition in combined modality therapy: A comprehensive review. Int J Cancer (Radiat Oncol Invest) 96: 1-10, 2001.
14. Lo TC, Wiley AJ, Ansfield FJ, Brandenburg JH, Davis HL Jr, Gollin FF, Johnson RO, Ramirez G and Vermund H: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126: 229-235, 1976.
15. Byfield JE, Calabro-Jones, Klisak I and Kulhanian F: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiot Oncol Biol Phys 8: 1923-1933, 1982.
16. Smalley S, Kimler B and Evans R: 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 20: 207-211, 1991.
17. Nakashima T, Komiyama S, Makishima K and Hiroto I: Antitumor effect of UFT against head and neck malignant tumors: Clinical and histochemical study. Gan to Kagaku Ryoho 8: 885-891, 1981. (Japanese)
18. Mercke C: UFT/leucovorin in advanced squamous cell carcinoma of head and neck administered with radiotherapy. Oncology 14(Suppl 9): 79-81, 2000.
19. Colevas AD, Amrein PC, Gomolin H, Barton JJ, Read RR, Adak S, Benner S, Costello R and Posner MR: A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck. Cancer 92: 326-331, 2001.
20. Tsukuda M and Miyake H: Maintenance chemotherapy with UFT for head and neck carcinoma. Oncology 14(Suppl 9): 93-95, 2000.
21. Fujii M, Ohno Y, Tokumary Y, Imanishi Y, Kanke M, Kanzaki J and Inuyama Y: Adjuvant chemotherapy with oral tegafur and uracil for maxillary sinus carcinoma. Oncology 55: 109-115, 1998.
22. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME and Witshaw E: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748-1756, 1989.
23. Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J and Doroshow J: Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II study. J Clin Oncol 19: 442-447, 2001.
24. Choy H, Akerley W, Safran H, Graziano S, chung C, Williams T, Cole B and Kennedy T: Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16: 3316-3322, 1998.
25. Takahashi H, Yao K, Sawaki S, Kubota A, Tsukuda M, Miyake H, Horiuchi M, Takeyama I, Kikuchihara M, Kubota T, Unno H, Hattori Y and Tsurukudo K: Investigation of UFT and radiation combination therapy of head and neck cancer mainly in laryngeal cancer. Gan to Kagaku Ryoho 17: 2037-2042, 1990. (Japanese)
26. Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S and Wiltshaw E: Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10: 520-528, 1992.